National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

exatecan mesylate
A semisynthetic, water-soluble derivative of camptothecin with antineoplastic activity. Exatecan mesylate inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA and inhibiting religation of DNA breaks, thereby inhibiting DNA replication and triggering apoptotic cell death. This agent does not require enzymatic activation and exhibits greater potency than camptothecin and other camptothecin analogues. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Exatecan
Code name:DX-8951f



Previous:Evacet, everolimus, Evista, Evoxac, ex vivo-expanded HER2-specific T cells
Next:exemestane, Exherin, exisulind, Exjade, Extren

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov